Dexcom Kiboshes Insulet Merger Rumors
Executive Summary
Bloomberg reported on 23 May that Dexcom is considering acquiring Insulet to become a diabetes tech giant. Dexcom said on 31 May that it is not in “active discussions” about a merger with anyone right now.
You may also be interested in...
Dexcom Raises Another Billion, But Why?
The company’s cash balance at the end of last quarter was more than enough to weather most storms – so why has Dexcom raised more money?
Minute Insight: Insulet Launches Omnipod 5 US-Wide Following Trial Period
After six months, the Omnipod 5 has seen its limited market launch expanded to cover the entirety of the US market.
ADA 2022 Wrap Up: Iterative Progress On Glucose Control, No Big Surprises
The major players in the diabetes tech sector announced new and re-hashed old clinical data at this year’s American Diabetes Association Scientific Sessions in New Orleans.